Valerio Therapeutics's total assets for Q2 2024 were €29.34M, a decrease of -16.82% from the previous quarter. FR:ALVIO total liabilities were €25.32M for the fiscal quarter, a 23.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.